Skip to main content
. 2018 Mar 26;8(5):647–652. doi: 10.3892/mco.2018.1595

Table III.

The postoperative complications.

Complications LABA + LAMA group (n=13) (%) LAMA (n=19) (%) P-value
Pulmonary complications 2 (15) 8 (42) 0.109
  Pneumonia 0 (0) 5 (26) 0.044
  Acute respiratory failure 0 (0) 2 (11) 0.227
  Chronic respiratory failure 2 (15) 6 (32) 0.299
Cardiovascular complications 3 (23) 3 (16) 0.604
  Atrial fibrillation 2 (15) 3 (16) 0.975

Values are shown as numbers (%). LAMA, long-acting muscarinic antagonist; LABA, long-acting β2-agonist.